164 related articles for article (PubMed ID: 33880476)
1. An AI-guided signature reveals the nature of the shared proximal pathways of host immune response in MIS-C and Kawasaki disease.
Sahoo D; Katkar GD; Shimizu C; Kim J; Khandelwal S; Tremoulet AH; Kanegaye J; ; Bocchini J; Das S; Burns JC; Ghosh P
bioRxiv; 2021 Aug; ():. PubMed ID: 33880476
[TBL] [Abstract][Full Text] [Related]
2. An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease.
Ghosh P; Katkar GD; Shimizu C; Kim J; Khandelwal S; Tremoulet AH; Kanegaye JT; ; Bocchini J; Das S; Burns JC; Sahoo D
Nat Commun; 2022 May; 13(1):2687. PubMed ID: 35577777
[TBL] [Abstract][Full Text] [Related]
3. AI-guided discovery of the invariant host response to viral pandemics.
Sahoo D; Katkar GD; Khandelwal S; Behroozikhah M; Claire A; Castillo V; Tindle C; Fuller M; Taheri S; Rogers TF; Beutler N; Ramirez SI; Rawlings SA; Pretorius V; Smith DM; Burton DR; Alexander LEC; Duran J; Crotty S; Dan JM; Das S; Ghosh P
bioRxiv; 2021 Apr; ():. PubMed ID: 32995790
[TBL] [Abstract][Full Text] [Related]
4. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease.
Esteve-Sole A; Anton J; Pino-Ramirez RM; Sanchez-Manubens J; Fumadó V; Fortuny C; Rios-Barnes M; Sanchez-de-Toledo J; Girona-Alarcón M; Mosquera JM; Ricart S; Launes C; de Sevilla MF; Jou C; Muñoz-Almagro C; González-Roca E; Vergara A; Carrillo J; Juan M; Cuadras D; Noguera-Julian A; Jordan I; Alsina L
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33497356
[TBL] [Abstract][Full Text] [Related]
5. Laboratory parameters between multisystem inflammatory syndrome in children and Kawasaki disease.
Zhou C; Zhao Y; Wang X; Huang Y; Tang X; Tang L
Pediatr Pulmonol; 2021 Dec; 56(12):3688-3698. PubMed ID: 34583417
[TBL] [Abstract][Full Text] [Related]
6. Distinguishing Between Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children and the Kawasaki Disease: Development of Preliminary Criteria Based on the Data of the Retrospective Multicenter Cohort Study.
Kostik MM; Bregel LV; Avrusin IS; Dondurei EA; Matyunova AE; Efremova OS; Isupova EA; Kornishina TL; Masalova VV; Snegireva LS; Shprakh VV; Kozlov YA; Kalashnikova OV; Chasnyk VG
Front Pediatr; 2021; 9():787353. PubMed ID: 34858909
[No Abstract] [Full Text] [Related]
7. Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease.
Bukulmez H
Curr Rheumatol Rep; 2021 Jul; 23(8):58. PubMed ID: 34216296
[TBL] [Abstract][Full Text] [Related]
8. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review.
Cherqaoui B; Koné-Paut I; Yager H; Bourgeois FL; Piram M
Rheumatology (Oxford); 2021 Oct; 60(10):4530-4537. PubMed ID: 33493353
[TBL] [Abstract][Full Text] [Related]
9. Erythema and Induration of Bacillus Calmette-Guérin Scar Associated With Multisystem Inflammatory Syndrome in Children in Japan: A Case Report.
Tsuboya N; Makino H; Mitani Y; Ito M; Ohya K; Morimoto M; Hanaki R; Yodoya N; Ohashi H; Sawada H; Sugiyama K; Hirayama M
Front Pediatr; 2022; 10():849473. PubMed ID: 35359902
[TBL] [Abstract][Full Text] [Related]
10. Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors.
Yang CA; Huang YL; Chiang BL
J Formos Med Assoc; 2022 Mar; 121(3):623-632. PubMed ID: 34193364
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2.
Yeo WS; Ng QX
Med Hypotheses; 2020 Nov; 144():110263. PubMed ID: 33254568
[TBL] [Abstract][Full Text] [Related]
12. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
Zhang QY; Xu BW; Du JB
World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
[TBL] [Abstract][Full Text] [Related]
13. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.
Fabi M; Filice E; Biagi C; Andreozzi L; Palleri D; Mattesini BE; Rizzello A; Gabrielli L; Ghizzi C; Di Luca D; Caramelli F; De Fanti A; Lanari M
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696451
[TBL] [Abstract][Full Text] [Related]
14. A Review of Coronaviruses Associated With Kawasaki Disease: Possible Implications for Pathogenesis of the Multisystem Inflammatory Syndrome Associated With COVID-19.
Shahbaz FF; Martins RS; Umair A; Ukrani RD; Jabeen K; Sohail MR; Khan E
Clin Med Insights Pediatr; 2022; 16():11795565221075319. PubMed ID: 35197719
[TBL] [Abstract][Full Text] [Related]
15. The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection.
Berardicurti O; Conforti A; Ruscitti P; Cipriani P; Giacomelli R
Expert Rev Clin Immunol; 2020 Dec; 16(12):1205-1215. PubMed ID: 33152254
[No Abstract] [Full Text] [Related]
16. Clinical features and outcome of MIS-C patients: an experience from Central Anatolia.
Alkan G; Sert A; Oz SKT; Emiroglu M; Yılmaz R
Clin Rheumatol; 2021 Oct; 40(10):4179-4189. PubMed ID: 33956250
[TBL] [Abstract][Full Text] [Related]
17. Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean.
Ozsurekci Y; Gürlevik S; Kesici S; Akca UK; Oygar PD; Aykac K; Karacanoglu D; Sarıtas Nakip O; Ilbay S; Katlan B; Ertugrul İ; Cengiz AB; Basaran O; Cura Yayla BC; Karakaya J; Bilginer Y; Bayrakci B; Ceyhan M; Ozen S
Clin Rheumatol; 2021 Aug; 40(8):3227-3237. PubMed ID: 33576926
[TBL] [Abstract][Full Text] [Related]
18. Publishing in pandemic times: A bibliometric analysis of early medical publications on Kawasaki-like disease (MIS-C, PIMS-TS) related to SARS-CoV-2.
Morand A; Urbina D; Giovannini-Chami L; Fabre A
Arch Pediatr; 2021 Aug; 28(6):464-469. PubMed ID: 34140220
[TBL] [Abstract][Full Text] [Related]
19. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.
Lee PY; Day-Lewis M; Henderson LA; Friedman KG; Lo J; Roberts JE; Lo MS; Platt CD; Chou J; Hoyt KJ; Baker AL; Banzon TM; Chang MH; Cohen E; de Ferranti SD; Dionne A; Habiballah S; Halyabar O; Hausmann JS; Hazen MM; Janssen E; Meidan E; Nelson RW; Nguyen AA; Sundel RP; Dedeoglu F; Nigrovic PA; Newburger JW; Son MBF
J Clin Invest; 2020 Nov; 130(11):5942-5950. PubMed ID: 32701511
[TBL] [Abstract][Full Text] [Related]
20. Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic.
Della Paolera S; Valencic E; Piscianz E; Moressa V; Tommasini A; Sagredini R; Kiren V; Comar M; Taddio A
Front Pediatr; 2020; 8():624248. PubMed ID: 33708752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
